Skip to content

Clinical evaluation and treatment of voice tremor with botulinum toxin and propranolol.

Clinical evaluation and treatment of voice tremor with botulinum toxin and propranolol.

Status
Recruiting
Phases
Phase 4
Study type
Interventional
Source
REBEC
Registry ID
RBR-389mzn
Enrollment
Unknown
Registered
2012-01-31
Start date
2011-04-01
Completion date
Unknown
Last updated
2025-10-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Patients with vocal tremor

Interventions

Intervention Group 1: Patients with vocal tremor subjected to the use of Propranolol tablets orally in increasing doses and increments of 20-80 mg per day administered twice daily with a duration of 1
drug
HP4.018.158.692
D02.033.100.624.836

Sponsors

Universidade Federal de São Paulo
Lead Sponsor

Eligibility

Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: presence of vocal tremor to perceptual analysis and larynx; older than 18 years, both sexes

Exclusion criteria

Exclusion criteria: presence of laryngeal spasm during laryngoscopy or auditory perceptual, presence of lesions on laryngoscopy, patients with previous treatment, contraindication to propranolol or botulinum toxin

Design outcomes

Primary

MeasureTime frame
Perceptual-hearing evaluation of voice will be conducted through the scale RASAT whose main parameter is the measurement of vocal instability in a score of 0-3. The parameters of acoustic analysis will be evaluated: Fundamental frequency; Standard deviation of Fundamental Frequency; Variability of Fundamental Frequency; Jitter and shimmer; Diagram phonatory deviation;

Secondary

MeasureTime frame
Assessment will be conducted through patient satisfaction visual analog scale 0-100 mm, with the parameters: Overall satisfaction Improved voice Decreased tremor Swallowing problems. Which week? Breathiness. Which week? Cough. Which week?

Countries

Brazil

Contacts

Public ContactBruno Moraes

Universidade Federal de São Paulo

moraesbruno.orl@hotmail.com+55 1155732740

Outcome results

None listed

Source: REBEC (via WHO ICTRP)